BRPI0815595A2 - Composição antifúngica - Google Patents

Composição antifúngica

Info

Publication number
BRPI0815595A2
BRPI0815595A2 BRPI0815595-0A2A BRPI0815595A BRPI0815595A2 BR PI0815595 A2 BRPI0815595 A2 BR PI0815595A2 BR PI0815595 A BRPI0815595 A BR PI0815595A BR PI0815595 A2 BRPI0815595 A2 BR PI0815595A2
Authority
BR
Brazil
Prior art keywords
fungal composition
fungal
composition
Prior art date
Application number
BRPI0815595-0A2A
Other languages
English (en)
Inventor
Christian Bucher
Guenter Ditzinger
Estelle Dubois
Delphine Marchaud
Original Assignee
Basilea Pharmaceutica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basilea Pharmaceutica Ag filed Critical Basilea Pharmaceutica Ag
Publication of BRPI0815595A2 publication Critical patent/BRPI0815595A2/pt
Publication of BRPI0815595A8 publication Critical patent/BRPI0815595A8/pt
Publication of BRPI0815595B1 publication Critical patent/BRPI0815595B1/pt
Publication of BRPI0815595B8 publication Critical patent/BRPI0815595B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI0815595A 2007-08-21 2008-08-20 composição antifúngica para administração oral, que é autoemulsificante em contato com uma fase aquosa, seu uso e produto farmacêutico BRPI0815595B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07114652 2007-08-21
EP07114652.6 2007-08-21
PCT/EP2008/060905 WO2009024590A2 (en) 2007-08-21 2008-08-20 Antifungal composition

Publications (4)

Publication Number Publication Date
BRPI0815595A2 true BRPI0815595A2 (pt) 2015-03-03
BRPI0815595A8 BRPI0815595A8 (pt) 2018-06-19
BRPI0815595B1 BRPI0815595B1 (pt) 2021-02-09
BRPI0815595B8 BRPI0815595B8 (pt) 2021-05-25

Family

ID=38656753

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0815595A BRPI0815595B8 (pt) 2007-08-21 2008-08-20 composição antifúngica para administração oral, que é autoemulsificante em contato com uma fase aquosa, seu uso e produto farmacêutico

Country Status (14)

Country Link
US (1) US8536208B2 (pt)
EP (1) EP2192893B1 (pt)
JP (1) JP5576279B2 (pt)
KR (1) KR101493546B1 (pt)
CN (1) CN101784259B (pt)
AU (1) AU2008290536B2 (pt)
BR (1) BRPI0815595B8 (pt)
CA (1) CA2697328C (pt)
ES (1) ES2551125T3 (pt)
MX (1) MX2010001730A (pt)
PL (1) PL2192893T3 (pt)
PT (1) PT2192893E (pt)
WO (1) WO2009024590A2 (pt)
ZA (1) ZA201000925B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX340815B (es) * 2011-12-02 2016-07-27 Colgate Palmolive Co Composicion de cuidado bucal que comprende isobutil magnolol.
CA3028927C (en) * 2016-06-20 2024-01-09 Capretto Ehf. Thermostable formulation of biologically active substances
CN105943500B (zh) * 2016-07-08 2019-01-04 河南省立眼科医院 一种含有艾沙康唑的眼用纳米胶束抗真菌溶液
WO2018219804A1 (en) * 2017-06-02 2018-12-06 Bayer Pharma Aktiengesellschaft Self-microemulsifying drug delivery systems
GB201813229D0 (en) * 2018-08-14 2018-09-26 Ocutec Ltd Formulation
KR20250008895A (ko) * 2022-05-12 2025-01-16 주식회사 지뉴브 안정한 액상 제약 제제
TW202541814A (zh) 2023-11-30 2025-11-01 瑞士商巴塞利亞阿爾斯維爾藥業國際股份有限公司 用於治療真菌感染的藥物組合

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6054136A (en) 1993-09-30 2000-04-25 Gattefosse S.A. Orally administrable composition capable of providing enhanced bioavailability when ingested
NZ270418A (en) 1994-02-07 1997-09-22 Eisai Co Ltd Polycyclic triazole & imidazole derivatives, antifungal compositions
AU2931399A (en) 1998-03-06 1999-09-20 F. Hoffmann-La Roche Ag 3-(4-(4-cyanophenyl)thiazol-2-y))-1-(1h-1,2,4-triazol-1-yl) -butan-2-ol derivatives having antifungal activity
WO1999056727A2 (en) * 1998-05-07 1999-11-11 Elan Corporation, Plc Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems
CA2388320C (en) 1999-11-02 2009-12-15 Basilea Pharmaceutica Ag N-substituted carbamoyloxyalkyl-azolium derivatives
JP2001302544A (ja) * 1999-12-10 2001-10-31 Takeda Chem Ind Ltd 経口用医薬組成物
US20030072807A1 (en) * 2000-12-22 2003-04-17 Wong Joseph Chung-Tak Solid particulate antifungal compositions for pharmaceutical use
FR2827770B1 (fr) 2001-07-27 2005-08-19 Gattefosse Ets Sa Composition pharmaceutique a usage oral comprenant un principe actif susceptible de subir un important effet de premier passage intestinal
US20050186142A1 (en) * 2002-10-25 2005-08-25 Foamix Ltd. Kit and composition of imidazole with enhanced bioavailability
EP1498123A1 (en) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Emulsifying systems containing azetidine derivatives
FR2861992B1 (fr) * 2003-11-10 2007-07-20 Sanofi Synthelabo Composition pharmaceutique destinee a l'administration orale d'un derive de pyrazole-3-carboxamide.
EP1715847A1 (en) * 2003-12-23 2006-11-02 Tibotec Pharmaceuticals Ltd. Self-microemulsifying drug delivery systems of a hiv protease inhibitor6
FR2873585B1 (fr) * 2004-07-27 2006-11-17 Aventis Pharma Sa Nouvelles formulations galeniques de principes actifs
MX2007006183A (es) * 2004-11-24 2007-09-11 Merck & Co Inc Formulaciones farmaceuticas liquidas y semisolidas para administracion oral de una amida sustituida.
WO2007038796A1 (en) * 2005-09-29 2007-04-05 Repros Therapeutics Inc. Formulations with improved bioavailability, comprising a steroid derivative and a polyglycolysed glyceride
CA2618705C (en) * 2005-11-07 2014-04-22 Murty Pharmaceuticals, Inc. Improved delivery of tetrahydrocannabinol

Also Published As

Publication number Publication date
BRPI0815595B8 (pt) 2021-05-25
CA2697328A1 (en) 2009-02-26
BRPI0815595A8 (pt) 2018-06-19
HK1141742A1 (en) 2010-11-19
US8536208B2 (en) 2013-09-17
PL2192893T3 (pl) 2015-12-31
CN101784259A (zh) 2010-07-21
KR101493546B1 (ko) 2015-02-16
MX2010001730A (es) 2010-03-10
PT2192893E (pt) 2015-11-09
US20110281918A1 (en) 2011-11-17
BRPI0815595B1 (pt) 2021-02-09
JP5576279B2 (ja) 2014-08-20
WO2009024590A2 (en) 2009-02-26
AU2008290536B2 (en) 2012-02-09
WO2009024590A3 (en) 2009-06-04
EP2192893B1 (en) 2015-08-19
CA2697328C (en) 2015-08-11
ES2551125T3 (es) 2015-11-16
ZA201000925B (en) 2010-10-27
JP2010536826A (ja) 2010-12-02
AU2008290536A1 (en) 2009-02-26
EP2192893A2 (en) 2010-06-09
CN101784259B (zh) 2013-03-27
KR20100064370A (ko) 2010-06-14

Similar Documents

Publication Publication Date Title
LTPA2018005I1 (lt) Farmacinė kompozicija
BRPI0813775A2 (pt) Composição
ATE528048T1 (de) Schweisshemmende/desodorierende zusammensetzung
BRPI0810634A2 (pt) Composições fungicidas
EP2170350A4 (en) SUBSTITUTED IMIDAZOHETEROCYCLES
ATE542825T1 (de) Substituierte piperidino-dihydrothienopyrimidine
DK2205737T3 (da) Mikromirer
EP2157090A4 (en) PYRAZINAMIDE COMPOUND
BRPI0721651A2 (pt) Composição farmacêutica
DE602008006301D1 (de) Koaxialnadelanordnung
EP2191827A4 (en) ANTIMYCOTIC COMPOSITION
EP2188984A4 (en) PREPARATION OF TRANSPORT FLOW PACKAGE (TS)
IT1392101B1 (it) Composizione comprendente isoflavoni
BRPI0810557A2 (pt) composição
BRPI0811274A2 (pt) Composição
DK2120884T3 (da) Farmaceutisk sammensætning
DK2125048T3 (da) Præparat
EP2149500A4 (en) Electron beam sterilizer
EP2216932A4 (en) BITS IDENTIFICATION CIRCUIT
PT2209464E (pt) Composição farmacêutica antimalárica
BRPI0811002A2 (pt) Composição biofertilizante
BRPI0820960A2 (pt) composição
EP2237903A4 (en) METAL BENDING APPARATUS
DE112008001216A5 (de) Magnetronplasmaanlage
FI20070655A0 (fi) Imuhihnakuljetin

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 09/02/2021, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 20/08/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF